Nature Communications (Oct 2018)

Variants in exons 5 and 6 of ACTB cause syndromic thrombocytopenia

  • Sharissa L. Latham,
  • Nadja Ehmke,
  • Patrick Y. A. Reinke,
  • Manuel H. Taft,
  • Dorothee Eicke,
  • Theresia Reindl,
  • Werner Stenzel,
  • Michael J. Lyons,
  • Michael J. Friez,
  • Jennifer A. Lee,
  • Ramona Hecker,
  • Michael C. Frühwald,
  • Kerstin Becker,
  • Teresa M. Neuhann,
  • Denise Horn,
  • Evelin Schrock,
  • Indra Niehaus,
  • Katharina Sarnow,
  • Konrad Grützmann,
  • Luzie Gawehn,
  • Barbara Klink,
  • Andreas Rump,
  • Christine Chaponnier,
  • Constanca Figueiredo,
  • Ralf Knöfler,
  • Dietmar J. Manstein,
  • Nataliya Di Donato

DOI
https://doi.org/10.1038/s41467-018-06713-0
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 17

Abstract

Read online

Genetic variants in ACTB and ACTG1 have been associated with Baraitser-Winter Cerebrofrontofacial syndrome. Here, the authors report of a syndromic thrombocytopenia caused by variants in ACTB exons 5 or 6 that compromise the organization and coupling of the cytoskeleton, leading to impaired platelet maturation.